Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 22 Aug 2025 – 20 Aug 2026, limited by Kotak Nifty Alpha 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Kotak Nifty Alpha 50 Index Fund | Nifty 500 |
|---|---|---|
| 22 Aug 2025 | ₹100.00 | ₹100.00 |
| 21 Sep 2025 | ₹101.16 | ₹102.15 |
| 22 Oct 2025 | ₹100.34 | ₹103.34 |
| 21 Nov 2025 | ₹100.24 | ₹103.48 |
| 21 Dec 2025 | ₹98.24 | ₹102.98 |
| 20 Jan 2026 | ₹94.26 | ₹99.81 |
| 20 Feb 2026 | ₹99.12 | ₹101.76 |
| 22 Mar 2026 | ₹90.64 | ₹92.77 |
| 21 Apr 2026 | ₹99.47 | ₹100.22 |
| 21 May 2026 | ₹101.12 | ₹98.31 |
| 21 Jun 2026 | ₹105.62 | ₹100.67 |
| 21 Jul 2026 | ₹105.55 | ₹101.57 |
| 20 Aug 2026 | ₹108.90 | ₹102.27 |
| Metric | Kotak Mahindra · Direct · IDCW NAV ₹10.90 Very High risk ★★★★☆ 1Y | Category median Index Funds · 271 funds |
|---|---|---|
| +8.90% | +5.06% | |
| — | +7.78% | |
| — | +8.94% | |
| — | +10.39% | |
| +8.90% | +7.54% | |
| +19.59% | — | |
| — | +8.12% | |
| — | +12.83% | |
| — | +11.97% | |
| Risk | ||
| 19.00% | 13.54% | |
| 0.13 | 0.16 | |
| 0.18 | 0.22 | |
| -15.24% | -15.77% | |
| Nifty 500 | — | |
| — | +0.53% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 98.0% | |
| 0.84% | 0.34% | |
| ₹32.12Cr | ₹191.88Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 175% | 38% | |
| Abhishek Bisen | — | |
| 22 Aug 2025 | — | |
| 50 | — | |
| 36.2% | — | |
| -1.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.